PresentationGood afternoon, everyone. I'm Dan Bray, Managing Director in the Morgan Stanley Healthcare Group. I have with me are Travis Dalton, CEO of Claritev; and Doug Garis, CFO. Guys, maybe we jump right into it.Maybe you could start by talking about a bit of the Claritev journey and where you guys are in that journey, focused on some of the recent success and looking forward strategic priorities.Travis DaltonCEO, President & Chairman Yes, happy to. Thank you all for being here. Appreciate it. Travis, C ...

Question-and-Answer SessionMaybe we could just start with an overview of the company for those who might be less familiar, or newer to the story? That would be great.Jennifer GoodCo-Founder, CEO, President, Interim Principal Financial Officer & Director Yes, happy to do that. And thank you to everyone that came. I see some old friends in the audience. And Judah, thank you to you and Morgan Stanley, our newest relationship, newest analyst. That's great. So Trevi has had a strong year. We are a single-asset c ...

Question-and-Answer SessionMaybe we could just start with an overview of the company for those who might be less familiar, or newer to the story? That would be great.Jennifer GoodCo-Founder, CEO, President, Interim Principal Financial Officer & Director Yes, happy to do that. And thank you to everyone that came. I see some old friends in the audience. And Judah, thank you to you and Morgan Stanley, our newest relationship, newest analyst. That's great. So Trevi has had a strong year. We are a single-asset c ...

PresentationEric SheridanMD & US Internet Analyst Okay. So in the interest of time, I think we're going to get started. It's great to welcome the team from Lyft back to the conference. This year, we've got Erin Brewer, CFO. Before we kick off, I am going to read the safe harbor, so stick with me. Before we start, Lyft would like to remind you that during the fireside chat today, they will make forward-looking statements, which involve risks and uncertainties that may cause actual results to differ materiall ...

Shares of Qualcomm Inc. NASDAQ: QCOM closed around $160 on Monday, once again running into resistance at a level they have struggled to clear since June. QUALCOMM TodayQCOMQUALCOMM$158.66 -1.58 (-0.99%) 52-Week Range$120.80▼$182.10Dividend Yield2.24%P/E Ratio15.30Price Target$182.82Add to WatchlistIt is the fourth time in as many months the stock has tested this level, and, compared to many of its peers, the chart is not a flattering one. And for many investors, Qualcomm has been a frustrating name to watc ...

PresentationEric SheridanMD & US Internet Analyst Okay. So in the interest of time, I think we're going to get started. It's great to welcome the team from Lyft back to the conference. This year, we've got Erin Brewer, CFO. Before we kick off, I am going to read the safe harbor, so stick with me. Before we start, Lyft would like to remind you that during the fireside chat today, they will make forward-looking statements, which involve risks and uncertainties that may cause actual results to differ materiall ...

President Donald Trump's administration on Tuesday rolled out an executive action aimed at limiting direct-to-consumer advertising for pharmaceuticals, with officials saying a recent Hims & Hers Healt... ...

The U.S. Food and Drug Administration will send out around 100 cease-and-desist enforcement notices and thousands of letters warning pharmaceutical companies that direct-to-consumer ads must comply wi... ...

Accessibility StatementSkip Navigation NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Luminar Technologies, Inc. (NASDAQ: LAZR) between March 20, 2025 and May 14, 2025, both dates inclusive (the "Class Period"), of the important September 22, 2025 lead plaintiff deadline. So what: If you purchased Luminar securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or c ...

PresentationRoss Cohen So really quickly on disclosures. So for important disclosures, please see the Morgan Stanley research disclosure website. And if you have any questions, please contact your Morgan Stanley sales representative. So thank you all for joining us for the Cartesian fireside chat. I'm really excited to welcome Carsten and Milos Miljkovic, the company's CEO and the CMO. Welcome, Carsten. Welcome, Milos. And I'm Ross Cohen, and I work in the health care investment banking at Morgan Stanley. S ...